BPC 157 in topical regeneration and oxidative stress modulation
doi: 10.1016/j.jhep.2024.04.008 11
A single dramatic transformation post says nothing about the persons muscle loss, rebound weight gain, or side effects six months later details that rarely make it into a 30-second reel
Consult your provider if you experience severe or persistent nausea and vomiting that prevents adequate food or fluid intake, signs of pancreatitis including severe abdominal pain , vision changes or signs of diabetic retinopathy progression if you have diabetes, severe constipation lasting more than a week despite interventions, rapid heart rate or chest pain, or complete lack of appetite suppression or weight loss after reaching 1mg dose for at least four weeks
Preclinical wound healing models, typically in rodents, represent another major area of GHK-Cu research
Discussing this with biotech/pharma sponsors and building some dose escalation buffer into a protocol to keep the participant in the study and manage these AEs (when possible) can be a good strategy to keep participants in the trial & improve their experience
